Calidi Biotherapeutics revenue was $0.00 for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CLDI annual revenue was $0.0, with -100% growth year-over-year.
CLDI past revenue growth
How has CLDI's revenue growth performed historically?
Calidi Biotherapeutics (NYSEMKT: CLDI) reported Q3 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Calidi Biotherapeutics's revenue was $0.00.
What was Calidi Biotherapeutics's revenue in 2023?
Calidi Biotherapeutics's annual revenue for the twelve months ending Dec 31, 2023 was $0.00, a 100% decrease year over year.
How much does Calidi Biotherapeutics make in a day?
Based on Calidi Biotherapeutics annual revenue for the past two years, CLDI makes an average of $61.64 per day.
What was Calidi Biotherapeutics's annual revenue growth in the past year?
As of Q1 2025, Calidi Biotherapeutics's revenue has grown null year over year. Calidi Biotherapeutics's revenue in the past year totaled $0.00.
How much does Calidi Biotherapeutics make in a year?
Calidi Biotherapeutics's revenue by year for the past two years is:
Calidi Biotherapeutics's revenue for the twelve months ending Dec 31, 2023 was $0.00, a 100% decrease year over year.
Calidi Biotherapeutics's annual revenue for Dec 31, 2022 was $45.00 thousand, a 89.98% decrease from 2021.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.